Australia markets close in 4 hours 50 minutes
  • ALL ORDS

    7,536.50
    -7.10 (-0.09%)
     
  • ASX 200

    7,237.20
    -4.00 (-0.06%)
     
  • AUD/USD

    0.7009
    +0.0005 (+0.07%)
     
  • OIL

    67.80
    +1.54 (+2.32%)
     
  • GOLD

    1,785.00
    +1.10 (+0.06%)
     
  • BTC-AUD

    69,572.11
    -1,807.31 (-2.53%)
     
  • CMC Crypto 200

    1,367.14
    -74.62 (-5.18%)
     
  • AUD/EUR

    0.6199
    +0.0012 (+0.20%)
     
  • AUD/NZD

    1.0378
    +0.0006 (+0.06%)
     
  • NZX 50

    12,614.73
    -61.77 (-0.49%)
     
  • NASDAQ

    15,712.04
    -278.76 (-1.74%)
     
  • FTSE

    7,122.32
    -6.89 (-0.10%)
     
  • Dow Jones

    34,580.08
    -59.72 (-0.17%)
     
  • DAX

    15,169.98
    -93.12 (-0.61%)
     
  • Hang Seng

    23,766.69
    -22.21 (-0.09%)
     
  • NIKKEI 225

    28,018.57
    -11.00 (-0.04%)
     

Cue Health to Announce Third Quarter 2021 Financial Results

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, October 27, 2021--(BUSINESS WIRE)--Cue Health Inc. (Nasdaq:HLTH), a healthcare technology company, announced today that it will release its third quarter 2021 financial results on Wednesday, November 10, 2021. In conjunction with the release, Cue will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (888) 708-0136 for domestic callers or (929) 517-9009 for international callers, using conference ID: 4474295. The live webinar of the call may be accessed by visiting the Events section of the Company’s website at investors.cuehealth.com. A replay of the webinar will be available on the Company’s website shortly after the conclusion of the call.

About Cue Health
Cue Health (Nasdaq:HLTH) is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health’s first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, and regulatory approval from India’s Central Drugs Standard Control Organisation. Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211027006032/en/

Contacts

Press
Cue Health
press@cuehealth.com

Investors:
Westwicke Partners
Caroline Corner
+1-415-202-5678
caroline.corner@westwicke.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting